Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The goal of the project is to develop five to ten promising and tested new compounds for fighting multidrug-resistant infection caused by staph and related microbes, including vancomycin-resistant Enterococcus. The five-year project will be led by Michael Gilmore, PhD.
Related Articles on Antibiotic-Resistant Bacteria:
Most Hospital Uniforms Carry Bacteria, Study Shows
Tennessee Hospitals Improve Quality, Infection Control
New Bill Would Require Facility-Wide Plan From New Jersey Hospitals to Prevent Spread of MRSA
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
